Emerging Indian NIPT Market
Our dedicated team of industry experts intensively monitored and analyzed all the emerging trends in the global molecular diagnostics market. According to their assessment, NIPT has fast emerged as the quickest growing segment. Players, who are actively establishing their base in the US, are also fanning out to the EU and APAC regions. Interestingly, despite catching up on the Chinese, Japanese and Australian markets, players are yet to enter the Indian market. This report has been made to act as a pristine source of business intelligence for players looking to enter the highly lucrative Indian NIPT market.
In their latest research study “Emerging Indian NIPT Market”, RNCOS analysts have identified various factors to showcase the immense potential of the Indian NIPT market. These factors like the number of births by the age of mother, rural and urban split of such births; affordability for NIPT; and regulatory scenario have been prudently analyzed to reflect a clear picture of the immense possibilities in the Indian NIPT market.
The report provides a depiction of macro-economic factors and healthcare infrastructure relevant in the context of NIPT. Our study reveals that in India, NIPT will be eagerly adopted by the booming IVF clinics that are witnessing a huge surge in fertility tourism. Also, India is home to a rapidly expanding network of pathology labs. In order to differentiate themselves from competition, organized players in the Indian diagnostic services market are looking forward to adopting new tests.
RNCOS has used its expertise in the Indian IVF and diagnostic services market to provide a relevant snapshot of these markets in the report. Leading players in both markets have been profiled with details about their infrastructure and analysis of their strengths and weaknesses, which will prove to be of value to NIPT players looking for partnering opportunities in India. Besides, to offer a glimpse of NIPT players in the global market to the diagnostic services players looking forward for partnerships and collaborations, detailed profiling of NIPT players, including the description of their test offering along with strengths and weaknesses analysis of their NIPT business has been provided.
The report also includes the findings from another RNCOS survey namely “Gynecologists survey to assess the potential for NIPT in India.” The survey was done between September-December 2012 with around 100 leading gynecologists in India. The key findings reveal that currently the awareness level of NIPT is very low in India. But when made aware about the benefits of NIPT, all gynecologists agreed that if launched tactfully, such a technology would have a tremendous scope to revolutionize the prenatal diagnosis scenario in India.
Insights from analysts will prove to be invaluable for NIPT players looking forward to entering the Indian market. Analysts have prudently assessed various factors to critically evaluate different possible business models and device apt marketing strategies. The report is a must buy for all players interested in the Indian NIPT market.
In their latest research study “Emerging Indian NIPT Market”, RNCOS analysts have identified various factors to showcase the immense potential of the Indian NIPT market. These factors like the number of births by the age of mother, rural and urban split of such births; affordability for NIPT; and regulatory scenario have been prudently analyzed to reflect a clear picture of the immense possibilities in the Indian NIPT market.
The report provides a depiction of macro-economic factors and healthcare infrastructure relevant in the context of NIPT. Our study reveals that in India, NIPT will be eagerly adopted by the booming IVF clinics that are witnessing a huge surge in fertility tourism. Also, India is home to a rapidly expanding network of pathology labs. In order to differentiate themselves from competition, organized players in the Indian diagnostic services market are looking forward to adopting new tests.
RNCOS has used its expertise in the Indian IVF and diagnostic services market to provide a relevant snapshot of these markets in the report. Leading players in both markets have been profiled with details about their infrastructure and analysis of their strengths and weaknesses, which will prove to be of value to NIPT players looking for partnering opportunities in India. Besides, to offer a glimpse of NIPT players in the global market to the diagnostic services players looking forward for partnerships and collaborations, detailed profiling of NIPT players, including the description of their test offering along with strengths and weaknesses analysis of their NIPT business has been provided.
The report also includes the findings from another RNCOS survey namely “Gynecologists survey to assess the potential for NIPT in India.” The survey was done between September-December 2012 with around 100 leading gynecologists in India. The key findings reveal that currently the awareness level of NIPT is very low in India. But when made aware about the benefits of NIPT, all gynecologists agreed that if launched tactfully, such a technology would have a tremendous scope to revolutionize the prenatal diagnosis scenario in India.
Insights from analysts will prove to be invaluable for NIPT players looking forward to entering the Indian market. Analysts have prudently assessed various factors to critically evaluate different possible business models and device apt marketing strategies. The report is a must buy for all players interested in the Indian NIPT market.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. INTRODUCTION TO NON-INVASIVE PRENATAL TESTING (NIPT)
3.1 MaterniT21 PLUS
3.2 Verifi
3.3 Panorama
3.4 Harmony
3.5 NIFTY
3.6 Bambni
4. ASSOCIATION OF DOWN’S SYNDROME RISK TO FETUS WITH MOTHER'S AGE
5. INDIA: MACRO-ECONOMIC FACTORS, HEALTHCARE INFRASTRUCTURE AND POPULATION DEMOGRAPHICS
5.1 Country Profile
5.2 Healthcare Spending
5.3 Hospitals, Sub-Centres, PHCs, CHCs
5.4 Pathology Labs
5.5 In-Vitro Fertilization Clinics
5.6 Population
6. NIPT INDIA: MARKET POTENTIAL
6.1 Potential Customer Base
6.2 Market Entry Strategy for Foreign Players
6.2.1 Whether one should Setup a Lab in India or Send Samples to Base Country?
6.2.2 Who should be Company's Face to Customer?
6.2.3 How should the Consumer be Allured?
6.3 Gynecologists and Obstetricians Outlook on NIPT in India: Survey Findings
6.3.1 Respondent Demographics
6.3.2 Current Challenges of Prenatal Testing: Indian Scenario
6.3.3 Awareness Level for NIPT
6.3.4 Gynecologists and Obstetricians Opinion
7. REGULATORY SCENARIO
8. KEY NIPT PLAYERS
8.1 Ariosa Diagnostics
8.1.1 Business Overview
8.1.2 Strengths and Weaknesses
8.2 Sequenom
8.2.1 Business Overview
8.2.2 Strengths and Weaknesses
8.3 Verinata
8.3.1 Business Overview
8.3.2 Strengths and Weaknesses
8.4 Natera
8.4.1 Business Overview
8.4.2 Strengths and Weaknesses
8.5 BGI
8.5.1 Business Overview
8.5.2 Strengths and Weaknesses
8.6 Berry Genomics
8.6.1 Business Overview
8.6.2 Strengths and Weaknesses
9. KEY PLAYERS IN INDIAN PATHOLOGICAL SERVICES MARKET
9.1 SRL Diagnostics
9.1.1 Business Overview
9.1.2 Strengths and Weaknesses
9.2 Dr. Lal Pathlabs
9.2.1 Business Overview
9.2.2 Strengths and Weaknesses
9.3 Metropolis India
9.3.1 Business Overview
9.3.2 Strengths and Weaknesses
9.4 Thyrocare
9.4.1 Business Overview
9.4.2 Strengths and Weaknesses
9.5 Quest Diagnostics
9.5.1 Business Overview
9.5.2 Strengths and Weaknesses
10. KEY IVF CLINICS IN INDIA
10.1 Bourn Hall Clinic
10.1.1 Business Overview
10.1.2 Strengths and Weaknesses
10.2 Southend Fertility and IVF Centre
10.2.1 Business Overview
10.2.2 Strengths and Weaknesses
10.3 Morpheus IVF Fertility Center
10.3.1 Business Overview
10.3.2 Strengths and Weaknesses
10.4 Bloom Fertility Center
10.4.1 Business Overview
10.4.2 Strengths and Weaknesses
10.5 Manipal Ankur
10.5.1 Business Overview
10.5.2 Strengths and Weaknesses
10.6 Cloudnine Fertility
10.6.1 Business Overview
10.6.2 Strengths and Weaknesses
10.7 Nova IVI Fertility
10.7.1 Business Overview
10.7.2 Strengths and Weaknesses
10.8 Srushti Test Tube Baby Center
10.8.1 Business Overview
10.8.2 Strengths and Weaknesses
2. RESEARCH METHODOLOGY
3. INTRODUCTION TO NON-INVASIVE PRENATAL TESTING (NIPT)
3.1 MaterniT21 PLUS
3.2 Verifi
3.3 Panorama
3.4 Harmony
3.5 NIFTY
3.6 Bambni
4. ASSOCIATION OF DOWN’S SYNDROME RISK TO FETUS WITH MOTHER'S AGE
5. INDIA: MACRO-ECONOMIC FACTORS, HEALTHCARE INFRASTRUCTURE AND POPULATION DEMOGRAPHICS
5.1 Country Profile
5.2 Healthcare Spending
5.3 Hospitals, Sub-Centres, PHCs, CHCs
5.4 Pathology Labs
5.5 In-Vitro Fertilization Clinics
5.6 Population
6. NIPT INDIA: MARKET POTENTIAL
6.1 Potential Customer Base
6.2 Market Entry Strategy for Foreign Players
6.2.1 Whether one should Setup a Lab in India or Send Samples to Base Country?
6.2.2 Who should be Company's Face to Customer?
6.2.3 How should the Consumer be Allured?
6.3 Gynecologists and Obstetricians Outlook on NIPT in India: Survey Findings
6.3.1 Respondent Demographics
6.3.2 Current Challenges of Prenatal Testing: Indian Scenario
6.3.3 Awareness Level for NIPT
6.3.4 Gynecologists and Obstetricians Opinion
7. REGULATORY SCENARIO
8. KEY NIPT PLAYERS
8.1 Ariosa Diagnostics
8.1.1 Business Overview
8.1.2 Strengths and Weaknesses
8.2 Sequenom
8.2.1 Business Overview
8.2.2 Strengths and Weaknesses
8.3 Verinata
8.3.1 Business Overview
8.3.2 Strengths and Weaknesses
8.4 Natera
8.4.1 Business Overview
8.4.2 Strengths and Weaknesses
8.5 BGI
8.5.1 Business Overview
8.5.2 Strengths and Weaknesses
8.6 Berry Genomics
8.6.1 Business Overview
8.6.2 Strengths and Weaknesses
9. KEY PLAYERS IN INDIAN PATHOLOGICAL SERVICES MARKET
9.1 SRL Diagnostics
9.1.1 Business Overview
9.1.2 Strengths and Weaknesses
9.2 Dr. Lal Pathlabs
9.2.1 Business Overview
9.2.2 Strengths and Weaknesses
9.3 Metropolis India
9.3.1 Business Overview
9.3.2 Strengths and Weaknesses
9.4 Thyrocare
9.4.1 Business Overview
9.4.2 Strengths and Weaknesses
9.5 Quest Diagnostics
9.5.1 Business Overview
9.5.2 Strengths and Weaknesses
10. KEY IVF CLINICS IN INDIA
10.1 Bourn Hall Clinic
10.1.1 Business Overview
10.1.2 Strengths and Weaknesses
10.2 Southend Fertility and IVF Centre
10.2.1 Business Overview
10.2.2 Strengths and Weaknesses
10.3 Morpheus IVF Fertility Center
10.3.1 Business Overview
10.3.2 Strengths and Weaknesses
10.4 Bloom Fertility Center
10.4.1 Business Overview
10.4.2 Strengths and Weaknesses
10.5 Manipal Ankur
10.5.1 Business Overview
10.5.2 Strengths and Weaknesses
10.6 Cloudnine Fertility
10.6.1 Business Overview
10.6.2 Strengths and Weaknesses
10.7 Nova IVI Fertility
10.7.1 Business Overview
10.7.2 Strengths and Weaknesses
10.8 Srushti Test Tube Baby Center
10.8.1 Business Overview
10.8.2 Strengths and Weaknesses
LIST OF FIGURES:
Figure 3-1: MaterniT21 PLUS Test Validation Results
Figure 3-2: Verifi Test Validation Results
Figure 3-3: Panorma Test Validation Results
Figure 3-4: Harmony Test Validation Results
Figure 3-5: NIFTY Test - Summary of Phase I Clinical Trial
Figure 3-6: NIFTY Test - Summary of Phase II Clinical Trial
Figure 4-1: Risk of Down’s syndrome with Rise in Maternal Age
Figure 5-1: Healthcare Spending (US$ per head), 2013-2018
Figure 5-2: Consumer Healthcare Spending (Billion US$), 2013-2018
Figure 5-3: Share of Diagnostic Services in Total Healthcare Expenditure (2013)
Figure 5-4: Breakup of Public Hospitals by Urban and Rural India (%), 2012
Figure 5-5: Breakup of Public Hospitals Beds by Urban and Rural India (%), 2012
Figure 5-6: Forecast for Share of Organized Pathology Services Market (2018)
Figure 5-7: IVF Clinics Presence by Number of Cycles Performed (%), 2013
Figure 5-8: IVF Clinics Presence by Number of Cycles Performed and Structure (%), 2013
Figure 5- 9: Population (Million), 2013-2018
Figure 5-10: Middle Class Population (Million), 2013-2018
Figure 6-1: India - Number of Births (Million), 2013-2018
Figure 6-2: India - Number of Births by Mother’s Risk of Down’s Syndrome (%), 2013
Figure 6-3: Number of Households Earning more than US$ 10,000 Per Annum (Million) 2013-2018
Figure 6-4: Factors Influencing the Indian NIPT Consumer
Figure 6-5: Respondent Gynecologists by Tier
Figure 6-6: Respondent Gynecologists by Region
Figure 6-7: Recommendations for Amniocentesis/CVS per Year
Figure 6-8: Challenges with Invasive Prenatal Tests
Figure 6-9: Are you Aware of DNA sequencing Based Non-Invasive Prenatal Tests (NIPT)?
Figure 6-10: Are you Aware of Technology used in NIPT?
Figure 6-11: What NIPT Players are you Aware of?
Figure 6-12: Respondents Who are Interested in NIPT Post Being Made Aware about its Advantages
Figure 6-13: Age-Based Profile of Patient to Whom Respondents will Recommend NIPT
Figure 6-14: Respondents Who Recommend Integration of NIPT with Regular Maternal Screens
Figure 3-1: MaterniT21 PLUS Test Validation Results
Figure 3-2: Verifi Test Validation Results
Figure 3-3: Panorma Test Validation Results
Figure 3-4: Harmony Test Validation Results
Figure 3-5: NIFTY Test - Summary of Phase I Clinical Trial
Figure 3-6: NIFTY Test - Summary of Phase II Clinical Trial
Figure 4-1: Risk of Down’s syndrome with Rise in Maternal Age
Figure 5-1: Healthcare Spending (US$ per head), 2013-2018
Figure 5-2: Consumer Healthcare Spending (Billion US$), 2013-2018
Figure 5-3: Share of Diagnostic Services in Total Healthcare Expenditure (2013)
Figure 5-4: Breakup of Public Hospitals by Urban and Rural India (%), 2012
Figure 5-5: Breakup of Public Hospitals Beds by Urban and Rural India (%), 2012
Figure 5-6: Forecast for Share of Organized Pathology Services Market (2018)
Figure 5-7: IVF Clinics Presence by Number of Cycles Performed (%), 2013
Figure 5-8: IVF Clinics Presence by Number of Cycles Performed and Structure (%), 2013
Figure 5- 9: Population (Million), 2013-2018
Figure 5-10: Middle Class Population (Million), 2013-2018
Figure 6-1: India - Number of Births (Million), 2013-2018
Figure 6-2: India - Number of Births by Mother’s Risk of Down’s Syndrome (%), 2013
Figure 6-3: Number of Households Earning more than US$ 10,000 Per Annum (Million) 2013-2018
Figure 6-4: Factors Influencing the Indian NIPT Consumer
Figure 6-5: Respondent Gynecologists by Tier
Figure 6-6: Respondent Gynecologists by Region
Figure 6-7: Recommendations for Amniocentesis/CVS per Year
Figure 6-8: Challenges with Invasive Prenatal Tests
Figure 6-9: Are you Aware of DNA sequencing Based Non-Invasive Prenatal Tests (NIPT)?
Figure 6-10: Are you Aware of Technology used in NIPT?
Figure 6-11: What NIPT Players are you Aware of?
Figure 6-12: Respondents Who are Interested in NIPT Post Being Made Aware about its Advantages
Figure 6-13: Age-Based Profile of Patient to Whom Respondents will Recommend NIPT
Figure 6-14: Respondents Who Recommend Integration of NIPT with Regular Maternal Screens
LIST OF TABLES:
Table 3-1: Comparison of Features of Key NIPT Tests in APAC NIPT Market
Table 3-2: Bambni Test - Summary of Phase I Clinical Trial
Table 3-3: Bambni Test - Summary of Phase II Clinical Trial
Table 5-1: Key Economic Indicators (2012)
Table 5-2: State-wise Breakup of Government Hospitals and Hospital Beds (2012)
Table 5-3: State-wise Breakup of Sub Centres, PHCs and CHCs (2012)
Table 5-4: Population Break-up by Age-Group (Million), 2013-2018
Table 6-1: India - Number of Births by Age of Mother and Region of Birth (2013)
Table 6-2: India - NIPT Potential Market (Million US$) and Potential Customers (2013)
Table 10-1: Presence of Bourn Hall Clinic
Table 10-2: Presence of Southend Fertility and IVF Center
Table 10-3: Presence of Morpheus IVF Fertility Center
Table 10-4: Presence of Bloom Fertility Center
Table 10-5: Presence of Manipal Ankur
Table 10-6: Presence of Cloudnine Fertility
Table 10-7: Presence of Nova IVI Fertility
Table 10-8: Presence of Srushti Test Tube Centre
Table 3-1: Comparison of Features of Key NIPT Tests in APAC NIPT Market
Table 3-2: Bambni Test - Summary of Phase I Clinical Trial
Table 3-3: Bambni Test - Summary of Phase II Clinical Trial
Table 5-1: Key Economic Indicators (2012)
Table 5-2: State-wise Breakup of Government Hospitals and Hospital Beds (2012)
Table 5-3: State-wise Breakup of Sub Centres, PHCs and CHCs (2012)
Table 5-4: Population Break-up by Age-Group (Million), 2013-2018
Table 6-1: India - Number of Births by Age of Mother and Region of Birth (2013)
Table 6-2: India - NIPT Potential Market (Million US$) and Potential Customers (2013)
Table 10-1: Presence of Bourn Hall Clinic
Table 10-2: Presence of Southend Fertility and IVF Center
Table 10-3: Presence of Morpheus IVF Fertility Center
Table 10-4: Presence of Bloom Fertility Center
Table 10-5: Presence of Manipal Ankur
Table 10-6: Presence of Cloudnine Fertility
Table 10-7: Presence of Nova IVI Fertility
Table 10-8: Presence of Srushti Test Tube Centre
